disulfiram has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, X | 1 |
| Ye, C | 1 |
| Yu, X | 1 |
| Zhang, Y | 1 |
| Hou, Y | 1 |
| Zheng, Q | 1 |
| Chen, Z | 1 |
| Wang, L | 1 |
| Weng, X | 1 |
| Yang, C | 1 |
| Liu, X | 1 |
| Yoshino, H | 1 |
| Yamada, Y | 1 |
| Enokida, H | 1 |
| Osako, Y | 1 |
| Tsuruda, M | 1 |
| Kuroshima, K | 1 |
| Sakaguchi, T | 1 |
| Sugita, S | 1 |
| Tatarano, S | 1 |
| Nakagawa, M | 1 |
2 other studies available for disulfiram and Cancer of Kidney
| Article | Year |
|---|---|
Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma.
Topics: Animals; Carcinoma, Renal Cell; Copper; Disulfiram; Ferroptosis; Kidney Neoplasms; Mice; NF-E2-Relat | 2023 |
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Renal Cell; | 2020 |